Concepedia

Michael L. Lu

ML

Statistics

Publications

37

Citations

3.6K

H-Index

26

Active since

1987

Affiliations

Harvard University(Current)

Brigham and Women's Hospital

Florida Atlantic University

Beth Israel Deaconess Medical Center

Dana-Farber Cancer Institute

Michael L. Lu is an author at Harvard University specializing in life sciences, molecular biology, and signal transduction.

ORCID

Publications per year

1987–2021

37

Publications

37

Deficiency of cathepsin S reduces atherosclerosis in LDL receptor–deficient mice

Galina K. Sukhova, Yaou Zhang, Jie-Hong Pan et al. · Journal of Clinical Investigation · 2003 · 344 citations · Full text

, , +17

Cholesterol-rich lipid rafts mediate akt-regulated survival in prostate cancer cells.

Liyan Zhuang, Jianqing Lin, Michael L. Lu et al. · PubMed · 2002 · 329 citations

, , +17

Deficiency of cathepsin S reduces atherosclerosis in LDL receptor–deficient mice

Galina K. Sukhova, Yaou Zhang, Jiehong Pan et al. · Journal of Clinical Investigation · 2003 · 310 citations · Full text

, , +17

Tetracycline Repressor, tetR, rather than the tetR–Mammalian Cell Transcription Factor Fusion Derivatives, Regulates Inducible Gene Expression in Mammalian Cells

Feng Yao, Tor Svensjö, Thomas Winkler et al. · Human Gene Therapy · 1998 · 257 citations

, , +15

Caveolin-1 Interacts with Androgen Receptor

Michael L. Lu, Michael C. Schneider, Yaxin Zheng et al. · Journal of Biological Chemistry · 2001 · 238 citations · Full text

, , +16

1–5 of 37